Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery

Journal of Controlled Release

Volumn 157, Issue 2, 2012, Pages 183-189

  Rogers, Mary Louise ^a   Rush, Robert Archer ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Antibody; Non viral; Receptor mediated gene delivery; Targeted gene delivery

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; EFFECTIVE THERAPY; FATAL DISEASE; GENE DELIVERY; IN-VIVO; NEUROLOGICAL DISEASE; NON-VIRAL GENE DELIVERY; NONVIRAL; NONVIRAL GENE THERAPY; NUCLEAR ENTRY; RECEPTOR-MEDIATED ENDOCYTOSIS; RECEPTOR-MEDIATED GENE DELIVERY; STEALTH AGENTS; TARGETED GENE DELIVERY; THERAPEUTIC AGENTS;

ANTIBODIES; DISEASE CONTROL; GENE TRANSFER; GLYCOLS; MOLECULAR BIOLOGY; POLYETHYLENE GLYCOLS;

GENE THERAPY;

ANTIBODY; DRUG CARRIER; GENE THERAPY AGENT; MACROGOL; MONOCLONAL ANTIBODY; PROTAMINE; SMALL INTERFERING RNA; TETANUS TOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; CELL POPULATION; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; ENDOCYTOSIS; GENE TARGETING; HUMAN; IMMUNOGENETICS; IN VIVO GENE TRANSFER; MOLECULAR BIOLOGY; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; RABIES VIRUS; REVIEW; VIRAL GENE THERAPY;

ANIMALS; ANTIBODIES, MONOCLONAL; CENTRAL NERVOUS SYSTEM DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 84855814958     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.08.026     Document Type: Review

References (110)

1. E. Marshall Gene therapy death prompts review of adenovirus vector Science 286 5448 1999 2244 2245 (Pubitemid 30016842)
2. T.-L. Wu, and H.C.J. Ertl Immune barriers to successful gene therapy Trends Mol. Med. 15 1 2009 32 39
3. L. Apolonia, S.N. Waddington, C. Fernandes, N.J. Ward, G. Bouma, M.P. Blundell, A.J. Thrasher, M.K. Collins, and N.J. Philpott Stable gene transfer to muscle using non-integrating lentiviral vectors Mol. Ther. 15 11 2007 1947 1954 (Pubitemid 350011734)
4. M.M. Doroudchi, K.P. Greenberg, J. Liu, K.A. Silka, E.S. Boyden, J.A. Lockridge, A.C. Arman, R. Janani, S.E. Boye, S.L. Boye, G.M. Gordon, B.C. Matteo, A.P. Sampath, W.W. Hauswirth, and A. Horsager Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness Mol. Ther. 19 7 2011 1220 1229
5. N.B. Woods, V. Bottero, M. Schmidt, C. von Kalle, and I.M. Verma Gene therapy: therapeutic gene causing lymphoma Nature 440 7088 2006 1123
6. W.J. Bowers, X.O. Breakefield, and M. Sena-Esteves Genetic therapy for the nervous system Hum. Mol. Genet. 20 R(1) 2011 R28 R41
7. T. Kiyota, S. Okuyama, R.J. Swan, M.T. Jacobsen, H.E. Gendelman, and T. Ikezu CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP + PS1 bigenic mice FASEB J. 24 8 2010 3093 3102
8. G.S. Ralph, P.A. Radcliffe, D.M. Day, J.M. Carthy, M.A. Leroux, D.C.P. Lee, L.-F. Wong, L.G. Bilsland, L. Greensmith, S.M. Kingsman, K.A. Mitrophanous, N.D. Mazarakis, and M. Azzouz Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model Nat. Med. 11 4 2005 429 433 (Pubitemid 40562334)
9. B.K. Kaspar Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model Science 301 5634 2003 839 842 (Pubitemid 36962626)
10. A. Shir, M. Ogris, E. Wagner, and A. Levitzki EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice Plos Med. 3 1 2006 e6
11. S.T. Lim, M. Airavaara, and B.K. Harvey Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS Pharmacol. Res. 61 1 2010 14 26
12. Y. Zhang, and W.M. Pardridge Near complete rescue of experimental Parkinson's disease with intravenous, non-viral GDNF gene therapy Pharm. Res. 26 5 2009 1059 1063
13. F.C. Pérez-Martínez, J. Guerra, I. Posadas, and V. Ceña Barriers to non-viral vector-mediated gene delivery in the nervous system Pharm. Res. 28 8 2011 1843 1858
14. S.-S. Kim, H. Garg, A. Joshi, and N. Manjunath Strategies for targeted nonviral delivery of siRNAs in vivo Trends Mol. Med. 15 11 2009 491 500
15. M. Morille, C. Passirani, A. Vonarbourg, A. Clavreul, and J.-P. Benoit Progress in developing cationic vectors for non-viral systemic gene therapy against cancer Biomaterials 29 24-25 2008 3477 3496
16. J.M. Bergen, I.-K. Park, P.J. Horner, and S.H. Pun Nonviral approaches for neuronal delivery of nucleic acids Pharm. Res. 25 5 2008 983 998
17. I. Navarro-Quiroga, J. Antonio Gonzalez-Barrios, F. Barron-Moreno, V. Gonzalez-Bernal, D.B. Martinez-Arguelles, and D. Martinez-Fong Improved neurotensin-vector-mediated gene transfer by the coupling of hemagglutinin HA2 fusogenic peptide and Vp1 SV40 nuclear localization signal Mol. Brain Res. 105 1-2 2002 86 97 (Pubitemid 35245615)
18. O. Boussif, F. Lezoualc'h, M. Zanta, M. Mergny, D. Scherman, B. Demeneix, and J. Behr A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 16 1995 7297 7301
19. Q. Shi, A.T. Nguyen, Y. Angell, D. Deng, C.-R. Na, K. Burgess, D.D. Roberts, F.C. Brunicardi, and N.S. Templeton A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo Gene Ther. 17 9 2010 1085 1097
20. B. Liang, M.-L. He, C.-Y. Chan, Y.-c. Chen, X.-P. Li, Y. Li, D. Zheng, M.C. Lin, H.-F. Kung, X.-T. Shuai, and Y. Peng The use of folate-PEG-grafted- hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat Biomaterials 30 23-24 2009 4014 4020
21. A. Malek, O. Merkel, L. Fink, F. Czubayko, T. Kissel, and A. Aigner In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(- PEG)/siRNA complexes Toxicol. Appl. Pharmacol. 236 1 2009 97 108
22. S.P. Wong, O. Argyros, S.J. Howe, and R.P. Harbottle Systemic gene transfer of polyethylenimine (PEI)-plasmid DNA complexes to neonatal mice J. Control. Release 150 3 2011 298 306
23. U. Lungwitz, M. Breunig, T. Blunk, and A. Göpferich Polyethylenimine-based non-viral gene delivery systems Eur. J. Pharm. Biopharm. 60 2 2005 247 266 (Pubitemid 40804565)
24. G. Jeudy, F. Salvadori, B. Chauffert, E. Solary, P. Vabres, and J. Chluba Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth Cancer Gene Ther. 15 11 2008 742 749
25. S. Patnaik, M. Arif, A. Pathak, R. Kurupati, Y. Singh, and K.C. Gupta Cross-linked polyethylenimine-hexametaphosphate nanoparticles to deliver nucleic acids therapeutics Nanomedicine 6 2 2010 344 354
26. H.-L. Jiang, Y.-K. Kim, R. Arote, J.-W. Nah, M.-H. Cho, Y.-J. Choi, T. Akaike, and C.-S. Cho Chitosan-graft-polyethylenimine as a gene carrier J. Control. Release 117 2 2007 273 280 (Pubitemid 46161875)
27. I.-D. Kim, C.-M. Lim, J.-B. Kim, H.Y. Nam, K. Nam, S.-W. Kim, J.-S. Park, and J.-K. Lee Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain J. Control. Release 142 3 2010 422 430
28. Z. Ma, J. Li, F. He, A. Wilson, B. Pitt, and S. Li Cationic lipids enhance siRNA-mediated interferon response in mice Biochem. Biophys. Res. Commun. 330 3 2005 755 759 (Pubitemid 40462151)
29. K. Miyawaki-Shimizu, D. Predescu, J. Shimizu, M. Broman, S. Predescu, and A.B. Malik siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2 2006 L405 L413
30. A. Sato, M. Takagi, A. Shimamoto, S. Kawakami, and M. Hashida Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice Biomaterials 28 7 2007 1434 1442 (Pubitemid 44959042)
31. M. Mechali Eukaryotic DNA replication origins: many choices for appropriate answers Nat. Rev. Mol. Cell Biol. 11 10 2010 728 738 728
32. S.C. Hyde, I.A. Pringle, S. Abdullah, A.E. Lawton, L.A. Davies, A. Varathalingam, G. Nunez-Alonso, A.-M. Green, R.P. Bazzani, S.G. Sumner-Jones, M. Chan, H. Li, N.S. Yew, S.H. Cheng, A.C. Boyd, J.C. Davies, U. Griesenbach, D.J. Porteous, D.N. Sheppard, F.M. Munkonge, E.W.F.W. Alton, and D.R. Gill CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression Nat. Biotechnol. 26 5 2008 549 551 (Pubitemid 351668040)
33. D.R. Gill, I.A. Pringle, and S.C. Hyde Progress and prospects: the design and production of plasmid vectors Gene Ther. 16 2 2009 165 171
34. O. Argyros, S.P. Wong, C. Fedonidis, O. Tolmachov, S.N. Waddington, S.J. Howe, M. Niceta, C. Coutelle, and R.P. Harbottle Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver J. Mol. Med. 89 5 2011 515 529
35. M.G. Toscano, Z. Romero, P. Muñoz, M. Cobo, K. Benabdellah, and F. Martin Physiological and tissue-specific vectors for treatment of inherited diseases Gene Ther. 18 2 2011 117 127
36. D. Berhanu, and R. Rush Targeted silencing of TrkA expression in rat forebrain neurons via the p75 receptor Neuroscience 153 4 2008 1115 1125
37. B.H. Liu, Y. Yang, J.F.R. Paton, F. Li, J. Boulaire, S. Kasparov, and S. Wang GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain Mol. Ther. 14 6 2006 872 882 (Pubitemid 44743124)
38. B. Liu, J.F. Paton, and S. Kasparov Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo BMC Biotechnol. 8 2008 49
39. K.M. Wagstaff, J.Y. Fan, M.A. De Jesus, D.J. Tremethick, and D.A. Jans Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting FASEB J. 22 7 2008 2232 2242 (Pubitemid 351952970)
40. A.A. Kale, and V.P. Torchilin Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes J. Drug Target. 15 7-8 2007 538 545 (Pubitemid 47209054)
41. K. Ma, M. Hu, Y. Qi, L. Qiu, Y. Jin, J. Yu, and B. Li Structure-transfection activity relationships with glucocorticoid-polyethyl- enimine conjugate nuclear gene delivery systems Biomaterials 30 22 2009 3780 3789
42. A.P. Lam, and D.A. Dean Progress and prospects: nuclear import of nonviral vectors Gene Ther. 17 4 2010 439 447
43. J. Zabner, A.J. Fasbender, T. Moninger, K.A. Poellinger, and M.J. Welsh Cellular and molecular barriers to gene transfer by a cationic lipid J. Biol. Chem. 270 32 1995 18997 19007
44. S. Zou, K. Scarfo, M.H. Nantz, and J.G. Hecker Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells Int. J. Pharm. 389 1-2 2010 232 243
45. G. Dorn, S. Patel, G. Wotherspoon, M. Hemmings-Mieszczak, J. Barclay, F.J.C. Natt, P. Martin, S. Bevan, A. Fox, P. Ganju, W. Wishart, and J. Hall siRNA relieves chronic neuropathic pain Nucleic Acids Res. 32 5 2004 e49
46. D. Thakker, F. Natt, D. Husken, H. van der Putten, R. Maier, D. Hoyer, and J. Cryan siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain Mol. Psychiatry 10 8 2005 782 789 714 (Pubitemid 41129051)
47. Y.-L. Wang, W. Liu, E. Wada, M. Murata, K. Wada, and I. Kanazawa Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA Neurosci. Res. 53 3 2005 241 249 (Pubitemid 41463777)
48. H. Wang, A. Ghosh, H. Baigude, C.-S. Yang, L. Qiu, X. Xia, H. Zhou, T.M. Rana, and Z. Xu Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression J. Biol. Chem. 283 23 2008 15845 15852
49. T.S. Zimmermann, A.C.H. Lee, A. Akinc, B. Bramlage, D. Bumcrot, M.N. Fedoruk, J. Harborth, J.A. Heyes, L.B. Jeffs, M. John, A.D. Judge, K. Lam, K. McClintock, L.V. Nechev, L.R. Palmer, T. Racie, I. Röhl, S. Seiffert, S. Shanmugam, V. Sood, J. Soutschek, I. Toudjarska, A.J. Wheat, E. Yaworski, W. Zedalis, V. Koteliansky, M. Manoharan, H.-P. Vornlocher, and I. Maclachlan RNAi-mediated gene silencing in non-human primates Nature 441 7089 2006 111 114
50. P.H. Tan, L.C. Yang, H.C. Shih, K.C. Lan, and J.T. Cheng Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat Gene Ther. 12 1 2005 59 66
51. E. Wagner, M. Zenke, M. Cotten, H. Beug, and M.L. Birnstiel Transferrin-polycation conjugates as carriers for DNA uptake into cells Proc. Natl. Acad. Sci. U. S. A. 87 9 1990 3410 3414
52. M. Ogris, and E. Wagner Tumor-targeted gene transfer with DNA polyplexes Somat. Cell Mol. Genet. 27 1-6 2002 85 95
53. J.A. Reddy, C. Abburi, H. Hofland, S.J. Howard, I. Vlahov, P. Wils, and C.P. Leamon Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors Gene Ther. 9 22 2002 1542 1550
54. J.J. Green, E. Chiu, E.S. Leshchiner, J. Shi, R. Langer, and D.G. Anderson Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells Nano Lett. 7 4 2007 874 879 (Pubitemid 46717725)
55. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 3 2010 182 195
56. J. Wang, J.D. Byrne, M.E. Napier, and J.M. Desimone More effective nanomedicines through particle design Small 7 14 2011 1919 1931
57. O. Déas, E. Angevin, C. Cherbonnier, A. Senik, B. Charpentier, J.P. Levillain, E. Oosterwijk, F. Hirsch, and A. Dürrbach In vivo-targeted gene delivery using antibody-based nonviral vector Hum. Gene Ther. 13 9 2002 1101 1114 (Pubitemid 34717856)
58. H. Kamiya, Y. Fujimura, I. Matsuoka, and H. Harashima Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes Biochem. Biophys. Res. Commun. 298 4 2002 591 597 (Pubitemid 35333699)
59. Y. Hu, K. Li, L. Wang, S. Yin, Z. Zhang, and Y. Zhang Pegylated immuno-lipopolyplexes: a novel non-viral gene delivery system for liver cancer therapy J. Control. Release 144 1 2010 75 81
60. J.M. Bergen, and S.H. Pun Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons J. Gene Med. 10 2 2008 187 197 (Pubitemid 351267160)
61. O. Germershaus, T. Merdan, U. Bakowsky, M. Behe, and T. Kissel Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors Bioconjug. Chem. 17 5 2006 1190 1199 (Pubitemid 44455327)
62. G.L. Lukacs, P. Haggie, O. Seksek, D. Lechardeur, N. Freedman, and A.S. Verkman Size-dependent DNA mobility in cytoplasm and nucleus J. Biol. Chem. 275 3 2000 1625 1629 (Pubitemid 30060778)
63. E.J. Kwon, J.M. Bergen, I.K. Park, and S.H. Pun Peptide-modified vectors for nucleic acid delivery to neurons J. Control. Release 132 3 2008 230 235
64. F. Alber, S. Dokudovskaya, L.M. Veenhoff, W. Zhang, J. Kipper, D. Devos, A. Suprapto, O. Karni-Schmidt, R. Williams, B.T. Chait, A. Sali, and M.P. Rout The molecular architecture of the nuclear pore complex Nature 450 7170 2007 695 701 (Pubitemid 350207701)
65. R.N. Cohen, M.A.E.M. van der Aa, N. Macaraeg, A.P. Lee, and F.C. Szoka Quantification of plasmid DNA copies in the nucleus after lipoplex and polyplex transfection J. Control. Release 135 2 2009 166 174
66. W.M. Pardridge Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses Bioconjug. Chem. 19 7 2008 1327 1338 (Pubitemid 352032329)
67. M. Lafon Rabies virus receptors J. Neurovirol. 11 1 2005 82 87 (Pubitemid 40458377)
68. C. Tuffereau, K. Schmidt, C. Langevin, F. Lafay, G. Dechant, and M. Koltzenburg The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection J. Virol. 81 24 2007 13622 13630 (Pubitemid 350247855)
69. P. Kumar, H. Wu, J.L. Mcbride, K.-E. Jung, M.H. Kim, B.L. Davidson, S.K. Lee, P. Shankar, and N. Manjunath Transvascular delivery of small interfering RNA to the central nervous system Nature 448 7149 2007 39 43 (Pubitemid 47037001)
70. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M.J.A. Wood Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat. Biotechnol. 29 4 2011 341 345
71. D. Martinez-Fong, I. Navarro-Quiroga, I. Ochoa, I. Alvarez-Maya, M.A. Meraz, J. Luna, and J.A. Arias-Montaño Neurotensin-SPDP-poly-L-lysine conjugate: a nonviral vector for targeted gene delivery to neural cells Brain Res. Mol. Brain Res. 69 2 1999 249 262 (Pubitemid 29253817)
72. J.A. Gonzalez-Barrios, M. Lindahl, M.J. Bannon, V. Anaya-Martínez, G. Flores, I. Navarro-Quiroga, L.E. Trudeau, J. Aceves, D.B. Martinez-Arguelles, R. Garcia-Villegas, I. Jiménez, J. Segovia, and D. Martinez-Fong Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats Mol. Ther. 14 6 2006 857 865 (Pubitemid 44793642)
73. J. Zeng, X. Wang, and S. Wang Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons Biomaterials 28 7 2007 1443 1451 (Pubitemid 46001462)
74. S. Salinas, G. Schiavo, and E.J. Kremer A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins Nat. Rev. Microbiol. 8 9 2010 645 655
75. K. Stockel, M. Schwab, and H. Thoenen Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons Brain Res. 99 1 1975 1 16
76. G. Lalli, and G. Schiavo Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR J. Cell Biol. 156 2 2002 233 239 (Pubitemid 34839905)
77. J. Herreros, G. Lalli, C. Montecucco, and G. Schiavo Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons J. Neurochem. 74 5 2000 1941 1950 (Pubitemid 30217649)
78. J. Ciriza, M. Moreno-Igoa, A.C. Calvo, G. Yague, J. Palacio, F.J. Miana-Mena, M.J. Munoz, P. Zaragoza, P. Brulet, and R. Osta A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model Restor. Neurol. Neurosci. 26 6 2008 459 465
79. R.-J. Chian, J. Li, I. Ay, S.A. Celia, B.B. Kashi, E. Tamrazian, J.C. Matthews, R.T. Bronson, A. Rossomando, R.B. Pepinsky, P.S. Fishman, R.H. Brown, and J.W. Francis IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice Brain Res. 1287 2009 1 19
80. A.C. Calvo, M. Moreno-Igoa, R. Mancuso, R. Manzano, S. Oliván, M.J. Muñoz, C. Penas, P. Zaragoza, X. Navarro, and R. Osta Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule Orphanet J. Rare Dis. 6 2011 10
81. L.G. Bilsland, E. Sahai, G. Kelly, M. Golding, L. Greensmith, and G. Schiavo Deficits in axonal transport precede ALS symptoms in vivo Proc Natl Acad Sci USA 107 47 2010 20523 20528
82. J. Chen, S. Gamou, A. Takayanagi, and N. Shimizu A novel gene delivery system using EGF receptor-mediated endocytosis FEBS Lett. 338 2 1994 167 169 (Pubitemid 24064958)
83. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties J. Pharmacol. Exp. Ther. 287 1 1998 408 415 (Pubitemid 29140227)
84. W. Suh, J.K. Chung, S.H. Park, and S.W. Kim Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells J. Control. Release 72 1-3 2001 171 178 (Pubitemid 32522355)
85. R. Kircheis, A. Kichler, G. Wallner, M. Kursa, M. Ogris, T. Felzmann, M. Buchberger, and E. Wagner Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery Gene Ther. 4 5 1997 409 418 (Pubitemid 27226583)
86. Y. Duan, J. Zheng, S. Han, Y. Wu, Y. Wang, and D. Li A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy J. Control. Release 127 2 2008 173 179
87. S.-J. Chiu, N.T. Ueno, and R.J. Lee Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine J. Control. Release 97 2 2004 357 369 (Pubitemid 38759492)
88. Y. Duan, C. Yang, Z. Zhang, J. Liu, J. Zheng, and D. Kong Poly(ethylene glycol)-grafted polyethylenimine modified with G250 monoclonal antibody for tumor gene therapy Hum. Gene Ther. 21 2 2010 191 198
89. E. Song, P. Zhu, S.-K. Lee, D. Chowdhury, S. Kussman, D.M. Dykxhoorn, Y. Feng, D. Palliser, D.B. Weiner, P. Shankar, W.A. Marasco, and J. Lieberman Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23 6 2005 709 717 (Pubitemid 41716361)
90. A.S. Manjappa, K.R. Chaudhari, M.P. Venkataraju, P. Dantuluri, B. Nanda, C. Sidda, K.K. Sawant, and R.S. Murthy Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor J. Control. Release 150 1 2011 2 22
91. W.M. Pardridge, J.L. Buciak, and P.M. Friden Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo J. Pharmacol. Exp. Ther. 259 1 1991 66 70
92. N. Shi, Y. Zhang, C. Zhu, R.J. Boado, and W.M. Pardridge Brain-specific expression of an exogenous gene after i.v. administration PNAS 98 22 2001 12754 12759 (Pubitemid 33026054)
93. Y. Zhang, F. Schlachetzki, Y. Zhang, R. Boado, and W. Pardridge Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter Hum. Gene Ther. 15 4 2004 339 350 (Pubitemid 38469776)
94. Q. Yan, and E.M. Johnson Jr. An immunohistochemical study of the nerve growth factor receptor in developing rats J. Neurosci. 8 9 1988 3481 3498
95. C.C. Ferri, F.A. Moore, and M.A. Bisby Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor J. Neurobiol. 34 1 1998 1 9 (Pubitemid 28032422)
96. K. Lowry, S. Murray, C. McLean, P. Talman, S. Mathers, E. Lopes, and S. Cheema A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis Amyotroph. Lateral Scler. 2 3 2001 127 134 (Pubitemid 34013605)
97. J.L. Seeburger, S. Tarras, H. Natter, and J.E. Springer Spinal cord motoneurons express p75NGFR and p145trkB mRNA in amyotrophic lateral sclerosis Brain Res. 621 1 1993 111 115 (Pubitemid 23242167)
98. S. Barati, P.R. Hurtado, S.H. Zhang, R. Tinsley, I.A. Ferguson, and R.A. Rush GDNF gene delivery via the p75(NTR) receptor rescues injured motor neurons Exp. Neurol. 202 1 2006 179 188 (Pubitemid 44344257)
99. M.L. Rogers, I. Atmosukarto, D.A. Berhanu, D. Matusica, P. Macardle, and R.A. Rush Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice J. Neurosci. Methods 158 1 2006 109 120 (Pubitemid 44550135)
100. O. Zelphati, L.S. Uyechi, L.G. Barron, and F.C. Szoka Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells Biochim Biophys Acta 1390 2 1998 119 133 (Pubitemid 28122331)
101. R. Kircheis, S. Schuller, S. Brunner, M. Ogris, K.H. Heider, W. Zauner, and E. Wagner Polycation-based DNA complexes for tumor-targeted gene delivery in vivo J. Gene Med. 1 2 1999 111 120 (Pubitemid 129631068)
102. M. Nishikawa Development of cell-specific targeting systems for drugs and genes Biol. Pharm. Bull. 28 2 2005 195 200 (Pubitemid 40879993)
103. D. Matusica, M. Fenech, M. Rogers, and R. Rush Characterization and use of the NSC-34 cell line for study of neurotrophin receptor trafficking J. Neurosci. Res. 86 3 2008 553 565 (Pubitemid 351204469)
104. N.E. Weisser, and J.C. Hall Applications of single-chain variable fragment antibodies in therapeutics and diagnostics Biotechnol. Adv. 27 4 2009 502 520
105. M. Better, C.P. Chang, R.R. Robinson, and A.H. Horwitz Escherichia coli secretion of an active chimeric antibody fragment Science 240 4855 1988 1041 1043
106. E.S. Ward, D. Güssow, A.D. Griffiths, P.T. Jones, and G. Winter Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli Nature 341 6242 1989 544 546 (Pubitemid 19252529)
107. S. David, B. Pitard, J.-P. Benoît, and C. Passirani Non-viral nanosystems for systemic siRNA delivery Pharmacol. Res. 62 2 2010 100 114
108. L. Xu, C.-C. Huang, W. Huang, W.-H. Tang, A. Rait, Y.Z. Yin, I. Cruz, L.-M. Xiang, K.F. Pirollo, and E.H. Chang Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes Mol. Cancer Ther. 1 5 2002 337 346
109. Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv Deliver siRNA and miRNA for cancer therapy Mol. Ther. 18 9 2010 1650 1656
110. M. Rothdiener, D. Müller, P.G. Castro, A. Scholz, M. Schwemmlein, G. Fey, O. Heidenreich, and R.E. Kontermann Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems J. Control. Release 144 2 2010 251 258